Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project von Ritchie, Craig W, Prof, Molinuevo, José Luis, MD, Truyen, Luc, MD, Satlin, Andrew, MD, Van der Geyten, Serge, PhD, Lovestone, Simon, Prof

Volltext

Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study von Murphy, Patricia, Moline, Margaret, Mayleben, David, Rosenberg, Russell, Zammit, Gary, Pinner, Kate, Dhadda, Shobha, Hong, Quan, Giorgi, Luigi, Satlin, Andrew

Volltext

Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies von Steinhoff, Bernhard J., Ben‐Menachem, Elinor, Ryvlin, Philippe, Shorvon, Simon, Kramer, Lynn, Satlin, Andrew, Squillacote, David, Yang, Haichen, Zhu, Jin, Laurenza, Antonio

Volltext

Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study von Farlow, Martin R., MD, Salloway, Stephen, MD, MS, Tariot, Pierre N., MD, Yardley, Jane, PhD, Moline, Margaret L., PhD, Wang, Qin, PhD, Brand-Schieber, Elimor, PhD, Zou, Heng, MS, Hsu, Timothy, MD, Satlin, Andrew, MD

Volltext

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial von Oparil, Suzanne, Prof, Yarows, Steven A, MD, Patel, Samir, MS, Fang, Hui, PhD, Zhang, Jack, MD, Satlin, Andrew, MD

Volltext

Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms von Lanctôt, Krista L., Amatniek, Joan, Ancoli-Israel, Sonia, Arnold, Steven E., Ballard, Clive, Cohen-Mansfield, Jiska, Ismail, Zahinoor, Lyketsos, Constantine, Miller, David S., Musiek, Erik, Osorio, Ricardo S., Rosenberg, Paul B., Satlin, Andrew, Steffens, David, Tariot, Pierre, Bain, Lisa J., Carrillo, Maria C., Hendrix, James A., Jurgens, Heidi, Boot, Brendon

Volltext

Perampanel for adjunctive treatment of partial‐onset seizures: A pooled dose–response analysis of phase III studies von Kramer, Lynn D., Satlin, Andrew, Krauss, Gregory L., French, Jacqueline, Perucca, Emilio, Ben‐Menachem, Elinor, Kwan, Patrick, Shih, Jerry J., Laurenza, Antonio, Yang, Haichen, Zhu, Jin, Squillacote, David

Volltext

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease von Farlow, Martin, Veloso, Felix, Moline, Margaret, Yardley, Jane, Brand-Schieber, Elimor, Bibbiani, Francesco, Zou, Heng, Hsu, Timothy, Satlin, Andrew

Volltext

Design of a Bayesian adaptive phase 2 proof-of-concept trial for BAN2401, a putative disease-modifying monoclonal antibody for the treatment of Alzheimer's disease von Satlin, Andrew, Wang, Jinping, Logovinsky, Veronika, Berry, Scott, Swanson, Chad, Dhadda, Shobha, Berry, Donald A

Volltext

Sundowning and Circadian Rhythms in Alzheimer's Disease von Volicer, Ladislav, Harper, David G., Manning, Barbara C., Goldstein, Rachel, Satlin, Andrew

Volltext

Disturbance of Endogenous Circadian Rhythm in Aging and Alzheimer Disease von Harper, David G., Volicer, Ladislav, Stopa, Edward G., McKee, Ann C., Nitta, Mika, Satlin, Andrew

Volltext

Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody von Logovinsky, Veronika, Satlin, Andrew, Lai, Robert, Swanson, Chad, Kaplow, June, Osswald, Gunilla, Basun, Hans, Lannfelt, Lars

Volltext

Pathologic Evaluation of the Human Suprachiasmatic Nucleus in Severe Dementia von Stopa, Edward G, Volicer, Ladislav, Kuo-Leblanc, Victoria, Harper, David, Lathi, Devayani, Tate, Barbara, Satlin, Andrew

Volltext

Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial von Calabrese, Joseph R, Durgam, Suresh, Satlin, Andrew, Vanover, Kimberly E, Davis, Robert E, Chen, Richard, Kozauer, Susan G, Mates, Sharon, Sachs, Gary S

Volltext

ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials von Wang, Jinping, Logovinsky, Veronika, Hendrix, Suzanne B, Stanworth, Stephanie H, Perdomo, Carlos, Xu, Lu, Dhadda, Shobha, Do, Ira, Rabe, Martin, Luthman, Johan, Cummings, Jeffrey, Satlin, Andrew

Volltext

Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia von Correll, Christoph U., Vanover, Kimberly E., Davis, Robert E., Chen, Richard, Satlin, Andrew, Mates, Sharon

Volltext

Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease von Satlin, Andrew, Volicer, Ladislav, Stopa, Edward G., Harper, David

Volltext

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients von Bohula, Erin A, Wiviott, Stephen D, McGuire, Darren K, Inzucchi, Silvio E, Kuder, Julia, Im, KyungAh, Fanola, Christina L, Qamar, Arman, Brown, Conville, Budaj, Andrzej, Garcia-Castillo, Armando, Gupta, Milan, Leiter, Lawrence A, Weissman, Neil J, White, Harvey D, Patel, Tushar, Francis, Bruce, Miao, Wenfeng, Perdomo, Carlos, Dhadda, Shobha, Bonaca, Marc P, Ruff, Christian T, Keech, Anthony C, Smith, Steven R, Sabatine, Marc S, Scirica, Benjamin M

Volltext

S221. THE EFFICACY OF LUMATEPERONE 42 MG IN THE TREATMENT OF SCHIZOPHRENIA SYMPTOMS ASSOCIATED WITH SOCIAL FUNCTIONING: POST HOC ANALYSIS OF AN ACUTE PLACEBO- AND ACTIVE-CONTROLLED... von Vanover, Kimberly, Davis, Robert, Durgam, Suresh, Huo, Jason, Mates, Sharon, Satlin, Andrew, Harvey, Philip D

Volltext

M205. LONG-TERM SAFETY OF LUMATEPERONE (ITI-007): METABOLIC EFFECTS IN A 1-YEAR STUDY von Satlin, Andrew, Durgam, Suresh, Vanover, Kimberly E, Davis, Robert E, Huo, Jason, Mates, Sharon, Correll, Christoph

Volltext